← Issue №14/ week of Oct 4, 2026/Colorectal

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

From GI Signals issue №14: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Colorectal guideline · Sep 30, 2026 · Gastroenterology · IF 25.1

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Guideline / reviewserrated polypcolorectal cancer screeningguidelinecolorectal cancer
Clinical takeawayScreen first-degree relatives of patients with SPS for CRC via colonoscopy. Perform meticulous colon inspection and frequent surveillance colonoscopy (compared to standard intervals) in SPS patients to reduce CRC risk. Consider colorectal surgery for SPS patients with cancer or unmanageable polyp burden. Germline genetic testing is indicated only in individuals meeting criteria for a known hereditary syndrome.
What it foundIndividuals with serrated polyposis syndrome (SPS), diagnosed based on WHO criteria (size, cumulative lifetime number, and location of serrated polyps), have an increased risk of prevalent and incident colorectal cancer (CRC).
ContextConfirms and refines current practice by emphasizing the need for rigorous surveillance and screening in SPS patients and their first-degree relatives, aligning with WHO diagnostic criteria.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Rex DK … Robertson DJ · Gastroenterology · IF 25.1 · PubMed ↗Permalink
← Read the whole of issue №14 Every paper GI Signals surfaces gets a page like this one. All issues